Learning Objectives:
After reading this article, the pharmacist should be able to:

• Describe the relationship between stress ulcer development and the risk of gastrointestinal bleeding in at-risk patient populations.
• Discuss alternative dosing strategies for acute gastric acid suppression in patients unable to tolerate oral medication, including suspension and intravenous formulations.
• Compare and contrast the histamine-2–receptor antagonist and proton pump inhibitor antisecretory classes.

Accreditation:

The University of Kentucky College of Pharmacy is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. This program is acceptable for 1.0 hour of continuing education credit (0.10 CEU) in states that recognize ACPE providers. A certificate awarding 1.0 contact hour will be offered only after the participant reads the article, completes and submits the post-test and evaluation form, and obtains a 70% passing grade on the post-test. The University of Kentucky College of Pharmacy complies with the Criteria for Quality for continuing education programming.

The University of Kentucky College of Medicine Office of Continuing Education presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgement while engaged in the practice of pharmacy. The content of the presentation is provided solely by presenters who have been selected because of recognized expertise in their field.

This program has been assigned ACPE# 022-999-02-089-H04 and will award 1.0 contact hour (0.10 CEU) of continuing education credit.



Release Date: May 1, 2002
Expiration Date: April 30, 2003

Target Audience:
Pharmacists

Authors and Credentials:
Jill A. Rebuck, PharmD, BCPS
Clinical Assistant Professor of Surgery, Trauma/Critical Care
Fletcher Allen Health Care
Department of Pharmacotherapy
Burlington, Vermont

Joseph Pisegna, MD
Associate Professor of Medicine
UCLA School of Medicine
Chief, Division of Gastroenterology
VA Greater Los Angeles Healthcare System
Los Angeles, California

Conflict-of-Interest Statement:
Dr. Rebuck is on the speakers’ bureaus for Wyeth Pharmaceuticals and AstraZeneca Pharmaceuticals.

Fee:
There is no fee for this activity.

This program is sponsored by

Continue to Lesson